Vivani Medical, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Vivani Medical, Inc. (VANI) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $313.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-13
- Vivani Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $313.00K, a 19.95% decline year-over-year.
- Vivani Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $312.00K, a 10.86% decline year-over-year.
- Vivani Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $276.00K, a 41.53% decline year-over-year.
- Vivani Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $391.00K, a 2.09% increase year-over-year.
- Vivani Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $1.48M, a 7.83% decline from fiscal 2024.
- Vivani Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $1.61M, a 13.63% decline from fiscal 2023.
- Vivani Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $1.86M, a 43.83% increase from fiscal 2022.
- Vivani Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $1.30M, a 22.30% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $313.00K 10-Q · filed 2026-08-13 | $625.00K derived: sum of 2 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $312.00K 10-Q · filed 2026-08-13 | |||||
| 2025-12-31 | $1.48M 10-K · filed 2026-03-26 | |||||
| 2025-09-30 | $276.00K 10-Q · filed 2025-11-13 | $667.00K derived: sum of 2 quarters · filed 2026-08-13 | $1.02M derived: sum of 3 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $391.00K 10-Q · filed 2026-08-13 | $741.00K derived: sum of 2 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $350.00K 10-Q · filed 2026-08-13 | |||||
| 2024-12-31 | $1.61M 10-K · filed 2026-03-26 | |||||
| 2024-09-30 | $472.00K 10-Q · filed 2025-11-13 | $855.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.21M derived: sum of 3 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $383.00K 10-Q · filed 2025-11-13 | $736.00K derived: sum of 2 quarters · filed 2025-11-13 | ||||
| 2024-03-31 | $353.00K 10-Q · filed 2025-11-13 | |||||
| 2023-12-31 | $1.86M 10-K · filed 2025-03-31 | |||||
| 2023-09-30 | $511.00K 10-Q · filed 2024-11-13 | $1.03M derived: sum of 2 quarters · filed 2024-11-13 | $1.40M derived: sum of 3 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $524.00K 10-Q · filed 2024-11-13 | $893.00K derived: sum of 2 quarters · filed 2024-11-13 | ||||
| 2023-03-31 | $369.00K 10-Q · filed 2024-11-13 | |||||
| 2022-12-31 | $1.30M 10-K · filed 2024-03-26 | |||||
| 2022-09-30 | $391.00K 10-Q · filed 2023-11-13 | $785.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.13M derived: sum of 3 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $394.00K 10-Q · filed 2023-11-13 | $13.00K 10-Q · filed 2022-08-12 | $734.00K derived: sum of 2 quarters · filed 2023-11-13 | |||
| 2022-03-31 | $340.00K 10-Q · filed 2023-11-13 | $13.00K 10-Q · filed 2022-05-16 | ||||
| 2021-12-31 | $1.67M 10-K · filed 2023-03-31 | $75.00K 10-K · filed 2022-03-29 | ||||
| 2021-09-30 | $389.00K 10-Q · filed 2022-11-14 | $19.00K 10-Q · filed 2021-11-12 | $783.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.23M derived: sum of 3 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $394.00K 10-Q · filed 2022-11-14 | $19.00K 10-Q · filed 2021-08-13 | $844.00K derived: sum of 2 quarters · filed 2022-11-14 | |||
| 2021-03-31 | $450.00K 10-Q · filed 2022-11-14 | $19.00K 10-Q · filed 2021-05-13 | ||||
| 2020-12-31 | $421.00K 10-K · filed 2022-03-29 | |||||
| 2020-09-30 | $27.00K 10-Q · filed 2021-11-12 | $115.00K derived: sum of 2 quarters · filed 2021-11-12 | $394.00K derived: sum of 3 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $88.00K 10-Q · filed 2021-11-12 | $367.00K derived: sum of 2 quarters · filed 2021-11-12 | ||||
| 2020-03-31 | $279.00K 10-Q · filed 2021-11-12 | |||||
| 2019-12-31 | $2.92M 10-K · filed 2021-03-16 | |||||
| 2019-09-30 | $686.00K 10-Q · filed 2020-11-12 | $1.54M derived: sum of 2 quarters · filed 2020-11-12 | $2.44M derived: sum of 3 quarters · filed 2020-11-12 | |||
| 2019-06-30 | $859.00K 10-Q · filed 2020-11-12 | $1.76M derived: sum of 2 quarters · filed 2020-11-12 | ||||
| 2019-03-31 | $898.00K 10-Q · filed 2020-11-12 | |||||
| 2018-12-31 | $3.59M 10-K · filed 2020-03-19 | |||||
| 2018-09-30 | $877.00K 10-Q · filed 2019-11-14 | $1.50M derived: sum of 2 quarters · filed 2019-11-14 | $2.79M derived: sum of 3 quarters · filed 2019-11-14 | |||
| 2018-06-30 | $627.00K 10-Q · filed 2019-11-14 | $1.91M 10-Q · filed 2018-08-07 | ||||
| 2018-03-31 | $1.28M 10-Q · filed 2019-11-14 | |||||
| 2017-12-31 | $3.78M 10-K · filed 2019-03-19 | |||||
| 2017-09-30 | $905.00K 10-Q · filed 2018-11-08 | $1.84M derived: sum of 2 quarters · filed 2018-11-08 | $2.82M derived: sum of 3 quarters · filed 2018-11-08 | |||
| 2017-06-30 | $935.00K 10-Q · filed 2018-11-08 | $1.92M 10-Q · filed 2018-08-07 | ||||
| 2017-03-31 | $981.00K 10-Q · filed 2018-11-08 | |||||
| 2016-12-31 | $3.37M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B |